DENVER, April 22, 2022 – A randomized controlled trial evaluates if selective early treatment of patent ductus arteriosus reduces death or bronchopulmonary dysplasia at 36 weeks in extreme preterm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback